Reimbursement Expansion To Fuel China Device Growth In 2011 (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary[Editor's note: This is part two of a two-part story. Part one appeared in PharmAsia News, Feb. 22, 2011.]
You may also be interested in...
Demand for sales talent is growing fast in 2012, particularly for device companies seeing a boost from China’s public hospital reforms.
China’s ambitious five-year plans will support policies to increase domestic R&D and import substitution for China’s biopharma and medical device industries.
Kanghui Bullish On Joint Implants Despite Looming Price Cuts; Mindray Undercutting U.S. Competition: China Earnings Roundup (Part 4)
Regulatory headwinds and price cuts led to a massive slowdown in China’s pharmaceutical industry in Q3, but China’s device makers are still enjoying fast growth.